Luteal Phase Support After Mild Ovulation Induction with Intrauterine Insemination: An On-Going Debate

dc.contributor.authorAytac, Pinar Caglar
dc.contributor.authorBulgan Kilicdag, Esra
dc.contributor.authorHaydardedeoglu, Bulent
dc.contributor.authorSimsek, Erhan
dc.contributor.authorCok, Tayfun
dc.contributor.authorCoban, Gonca
dc.contributor.orcID0000-0002-3285-5519en_US
dc.contributor.orcID0000-0002-0942-9108en_US
dc.contributor.orcID0000-0003-1244-7419en_US
dc.contributor.pubmedID26850073en_US
dc.contributor.researcherIDAAI-9974-2021en_US
dc.contributor.researcherIDAAC-9940-2020en_US
dc.contributor.researcherIDAAK-8872-2021en_US
dc.contributor.researcherIDAAH-5686-2020en_US
dc.date.accessioned2023-07-07T11:24:16Z
dc.date.available2023-07-07T11:24:16Z
dc.date.issued2016
dc.description.abstractObjective: To evaluate the effect of luteal phase support (LPS) using progesterone vaginal gel on pregnancy rate (PR) and live birth rate (LBR) during cycles in which controlled ovarian stimulation (COH) was performed using gonadotropins with intrauterine insemination (IUI) cycles in patients with unexplained infertility and polycystic ovarian syndrome.Materials and methods: From 2010 to 2015, all IUI cycles in which COH was performed using gonadotropins were evaluated retrospectively. LPS was not used until July 2013, after which vaginal progesterone gel was applied in the luteal phase of IUI cycles. Both groups of patients were evaluated in terms of the effect of LPS on PR and LBR.Results: In total, 1578 IUI cycles were evaluated, of which 481 were LPS (+) and 1097 LPS (-). PR and LBR per cycle were 10.6% and 7.4%, respectively, in the LPS (+) group, and 11.6% and 7.7%, respectively, in the LPS (-) group (p=0.31 and p=0.25). PR and LBR per patient were 17% and 12%, respectively, in the LPS (+) group, and 17.4% and 12.3%, respectively, in the LPS (-) group (p=0.48 and p=0.82).Conclusions: We found no difference in PR and LBR per cycle and per patient according to the use of LPS in IUI cycles in which COH was performed using gonadotropins. Thus, routine use of LPS in gonadotropin-stimulated cycles requires further research involving larger numbers of patients.en_US
dc.identifier.eissn1473-0766en_US
dc.identifier.endpage547en_US
dc.identifier.issn0951-3590en_US
dc.identifier.issue7en_US
dc.identifier.scopus2-s2.0-84958576784en_US
dc.identifier.startpage543en_US
dc.identifier.urihttp://hdl.handle.net/11727/9882
dc.identifier.volume32en_US
dc.identifier.wos000382552600008en_US
dc.language.isoengen_US
dc.relation.isversionof10.3109/09513590.2016.1138460en_US
dc.relation.journalGYNECOLOGICAL ENDOCRINOLOGYen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergien_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectGonadotrophen_US
dc.subjectinsinseminationen_US
dc.subjectluteal phase supporten_US
dc.subjectpregnancy rateen_US
dc.subjectvaginal progesterone gelen_US
dc.titleLuteal Phase Support After Mild Ovulation Induction with Intrauterine Insemination: An On-Going Debateen_US
dc.typearticleen_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: